The table below shows Crinetics Pharmaceuticals, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$124.70M
-$88.45M
-$52.86M
-$40.72M
-$13.54M
-$20.07M
Capital expenditure
$820.00K
$1.24M
$1.33M
$16.00K
$87.00K
$116.00K
Investing cash flow
-$252.36M
-$85.96M
$309.00K
$48.76M
-$43.38M
$32.50M
Dividends paid
-
-
-
-
CRNX operating cash flow (10-K history)
Crinetics Pharmaceuticals, Inc. reported operating cash flow of -$377.92M for fiscal year 2025. That is down 64.2% from -$230.19M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$5.47M (FY 2016) to -$377.92M. Figures come from the company's audited annual reports as filed with the SEC.